People with B12 deficiency are good candidates for injections
This allows researchers to make rapid adjustments to protocols and reduces the risk of long-term accumulation or side effects
Human evidence for precursors is mixed: some trials report good safety, but metabolic endpoints such as insulin sensitivity have not consistently replicated in people
The B12 component also helps combat the fatigue some patients experience during the early weeks of GLP-1 therapy
If you develop severe allergic reactions such as difficulty breathing, facial swelling, or widespread rash after a B12 injection, call 999 or go to A&E immediately, as these may indicate anaphylaxis, though this is extremely rare
5-Amino-1MQ for Diabetes and Metabolic Disorders NNMT is a potential biomarker for reduced insulin sensitivity, since higher activity of this enzyme has been linked to insulin resistance and type 2 diabetes [9]